Skip to main navigation
Skip to content
Cincor Logo
Menu
  • Home
  • About
  • Baxdrostat
    • Hypertension
      • Causes of Hypertension
      • Treatment for Hypertension
    • Chronic Kidney Disease
      • Causes of CKD
      • Treatment for CKD
    • Primary Aldosteronism
      • Aldosterone Diagnosis
      • Aldosterone Renin Ratio
    • Publications and Posters
  • Pipeline
  • News Releases
  • Contact

INVESTORS >> News Releases

News Release
February 21, 2023
CinCor Pharma Announces Receipt of Minutes from End-of-Phase 2 Meeting with the U.S. Food and Drug Administration on Planned Phase 3 Program of Baxdrostat
News Release
January 9, 2023
CinCor Pharma to be Acquired by AstraZeneca
  • Contact Us
  • Home
  • About
  • Baxdrostat
  • Pipeline
  • News Releases
  • Contact
Cincor Logo
© 2023 CinCor. All rights reserved
  • Privacy
  • LinkedIn
  • Twitter